To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Coley FluidColey Fluid is a modern reformulation of a historical cancer therapy called Coley Vaccine developed by Dr. William B. Coley that was an effective treatment for many forms of cancer including advanced breast cancer. Additional recommended knowledgeThe authors of a 1982 study concluded five year survival rates of historical Coley Vaccine patients is indistinguishable from five-year survival of modern patients. In 1999, researchers found ten-year survival was higher in historical Coley Vaccine patients compared to modern sarcoma, kidney and ovarian cancer patients. Coley Fluid is manufactured by MBVax Bioscience Inc, Ancaster, Canada. External link[1] |
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Coley_Fluid". A list of authors is available in Wikipedia. |
Last viewed
- Nut_allergy
- Traffic jam in the cell - A German-Polish team with scientists from Freiburg revealed how cells survive mistargeting of mitochondrial proteins
- Evolution of Cellular Power Stations - The protein OXA plays an important role in integrating protein molecules into mitochondria
- Scientists Unravel Life-saving Effect of Dexamethasone in COVID-19 - New approach for targeted drug development
- Category:Oncology_navigation_templates
